Name: Latest research reports of Divi's Laboratories Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 3
Author: Motilal Oswal

Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star

5960.5000 -187.50 (-3.05%)

NSE May 08, 2025 15:31 PM

60.06% Gain from 52W Low

Volume: 364.9K

Divi's Laboratories Ltd.

12 Aug 2019

5960.50

-3.05%

Adverse macro situation for raw materials impacts profitability

Neutral: Divi's Laboratories Ltd.

Motilal Oswal

Adverse macro situation for raw materials impacts profitability Motilal Oswal values your support in the Asiamoney Brokers Poll 2019 for...

Number of FII/FPI investors increased from 826 to 922 in Mar 2025 qtr.